Judge Approves “Cancer Risk” Label for Roundup in California
On January 2nd, Pribanic & Pribanic published a blog about the link between non-Hodgkin’s lymphoma – the most rapidly increasing cancer in the Western world – and the chemical glyphosate.
Glyphosate is the most commonly used pesticide ingredient in the world and the key ingredient in Roundup, a popular weed-killing product manufactured by the agrochemical giant Monsanto.
Just last week, a judge tentatively ruled that California can require Monsanto to label Roundup as a possible cancer threat. Meanwhile, the company continues to deny that their product poses a risk to humans.
Monsanto also bemoans the fact that California’s labeling law – Prop 65 – will have significant financial implications for the company. While this certainly may be true, it is by no means the company’s only monetary burden.
For years, Monsanto has been party to a suite of lawsuits by farm workers, cancer patients, and foreign countries for health and environmental damage. The company has also been the subject of investigations by the U.S. Department of Justice and U.S. Securities and Exchange Commission.
But as attorneys dedicated to protecting the public, our sympathies aren’t with Monsanto. We’re far more troubled by what all of this means for you.
Currently, Roundup is used on 250 crops in California alone, where over one third of the country’s vegetables and two-thirds of the country’s fruits and nuts are grown.
As the top producing agricultural state in the U.S., California would be the first to require Monsanto to label the product as a cancer risk.
However, the company has a year to change their labels. What’s more, just because a label is placed on bottles of Roundup doesn’t mean all farmers will suddenly stop using it. Therefore, exposures to glyphosate will continue.
If you or a loved one have been diagnosed with lymphoma, additional tests can determine whether pesticides played a role. Call the experienced attorneys and medically-trained team at Pribanic & Pribanic for a free consultation: 1-800-392-4529.